| Literature DB >> 6437007 |
J H Verheijen, D C Rijken, G T Chang, F E Preston, C Kluft.
Abstract
Fibrinolytic activity in plasma euglobulin fractions can be increased by oral administration of stanozolol. This increase is not caused by increased synthesis or release of tissue-type plasminogen activator. A decreased level of fast acting t-PA inhibition is very probably the cause of the higher activity. These results suggest that this inhibition has a regulatory role on fibrinolysis in vivo.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6437007
Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249